Researchers at the University of Southampton, UK, have developed a promising new way to bolster the body’s immune system response to cancer. In a...
Vous n'êtes pas connecté
Maroc - NEWS.MEDICAL.NET - A la Une - 15/Jan 04:45
Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a promising avenue to treat cancer, according to new research by UTHealth Houston.
Researchers at the University of Southampton, UK, have developed a promising new way to bolster the body’s immune system response to cancer. In a...
Researchers at the University of Southampton, UK, have developed a promising new way to bolster the body’s immune system response to cancer. In a...
The results of a Phase Ib/II clinical trial, published today in Nature Medicine, provide early evidence that immune-based approaches, such as...
The results of a Phase Ib/II clinical trial, published today in Nature Medicine, provide early evidence that immune-based approaches, such as...
Pancreatic cancer is one of the most deadly forms of cancer. The most common type is called pancreatic ductal adenocarcinoma, or PDAC. It is hard to...
Pancreatic cancer is one of the most deadly forms of cancer. The most common type is called pancreatic ductal adenocarcinoma, or PDAC. It is hard to...
Negotiable: Proclinical Staffing: Drive the discovery of next‑generation cancer therapies by advancing myeloid disease research from target...
A new study led by Stanford Medicine researchers offers promising news for people with a type of Parkinson’s disease caused by a specific genetic...
A new study led by Stanford Medicine researchers offers promising news for people with a type of Parkinson’s disease caused by a specific genetic...
A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the body. This is shown by a...